Patent · US Expired

Antitumoral ecteinascidin derivatives

US7202361B2 · kind B2 · utility

14Cited by
12References
70Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2001
Grant dateApr 10, 2007
Priority date—
Expiry dateApr 12, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.